65,437 trials
Amyotrophic Lateral Sclerosis
Primary: Accuracy of Typing With a BCI Keyboard by ALS Patients. — 81; 78; 75 percentage accuracy
Thrombosis
Primary: Thrombosis — 8; 6 participants
Moderate or Severe Submental Fullness
Primary: Percentage of Participants With a Clinician-Reported Submental Fat Rating Scale (CR-SMFRS) 1-grade Response — 58.3; 62.3; 34.5 percentage of participants — p=<0.001
Tibial Fractures
Primary: Duration of Time the Patient Was in the OR as a Measure of Effectiveness of the Treatment — 107.0 Minutes
Psoriasis
Primary: Dermatology Life Quality Index (DLQI) Scores — 17.25; 8.65; 4.51; 3.65 units on a scale
Glioblastoma Multiforme
Primary: Progression Free Survival PPX/RT Versus TMZ/RT for Patients With GBM Without Methylation — 31; 15 participants
Anaplastic Astrocytomas · Anaplastic Oligodendrogliomas · Glioblastomas (GBM)
Primary: Progression Free Survival, Assessed by Revised Assessment in Neuro-oncology (RANO) Criteria — 11 participants
Aqueous Deficient Dry Eye · Meibomium Gland Dysfunction
Primary: Visual Quality — 0.3; 0.32; 0.19; 0.3 microns
Solid Cancers
Primary: Percentage of Participants Who Experienced an Adverse Event — 33.3 percentage of participants
Acute Migraine
Primary: Number of Subjects Who Are Pain Free at the 2-hour Assessment — 69; 90 participants
Weight Loss
Primary: Percent Change in Weight — -1.27; -2.76 percent weight change
Healthy · Amyotrophic Lateral Sclerosis · Neuromuscular Disease
Primary: Accuracy of Typing With BCI Keyboard. — 85; 83; 83 percentage accuracy
Catheter-related Bladder Discomfort
Primary: Reduction of Catheter-associated Discomfort During the Post-operative Period in the Gynecologic Patient Using Mean Visual Analogue Scale (VAS) Measurments — 0.95; 0.97…
Nicotine Dependence
Primary: Accrual Rate (Eligibility Visit) — 85; 72 participants
Multiple Myeloma and Plasma Cell Neoplasm
Primary: Event-free Survival — 29 percentage of participants